Cardiomyopathy

Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Nutritional Assessment in Mitochondrial Cytopathy

Conditions:   Mitochondrial Diseases;   Mitochondrial Myopathies;   Mitochondrial Cytopathies
Intervention:  
Sponsor:   University Hospital Inselspital, Berne
Enrolling by invitation - verified February 2015

CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)

Condition:   Chagas Disease
Interventions:   Drug: Nifurtimox;   Drug: Benznidazole
Sponsors:   Universidad Autónoma de Bucaramanga;   Fundación Cardioinfantil Instituto de Cardiología;   Instituto Nacional de Salud (Colombia);   Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben
Not yet recruiting - verified February 2015

Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy

Condition:   Ischemic Cardiomyopathy
Interventions:   Biological: WJMSCs  Vs. placebo;   Biological: Placebo
Sponsors:   Navy General Hospital, Beijing;   First people's Hospital of Foshan, Beijing;   General Hospital of Armed Police, Beijing;   PLA General Hospital, Beijing
Not yet recruiting - verified January 2015

Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy

Condition:   Chagas Disease
Intervention:   Genetic: Gathering of samples of genetic material
Sponsor:   Hospital Sao Rafael
Not yet recruiting - verified February 2015

First in Human Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Drug: MYK-461
Sponsor:   MyoKardia, Inc.
Recruiting - verified February 2015

Effect of GS-6615 on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Interventions:   Drug: GS-6615;   Drug: Placebo
Sponsor:   Gilead Sciences
Recruiting - verified February 2015

The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Condition:   Arrhythmogenic Right Ventricular Cardiomyopathy
Intervention:   Device: 80 lead ECG
Sponsor:   The Leeds Teaching Hospitals NHS Trust
Completed - verified November 2014

A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis

Condition:   TTR-mediated Amyloidosis
Intervention:   Drug: Revusiran (ALN-TTRSC)
Sponsor:   Alnylam Pharmaceuticals
Recruiting - verified February 2015

HeartMate III™ IDE Clinical Study Protocol

Condition:   Advanced Refractory Left Ventricular Heart Failure
Interventions:   Device: HeartMate III LVAS;   Device: HeartMate II LVAS
Sponsor:   Thoratec Corporation
Recruiting - verified February 2015

Thoratec Corporation HeartMate III™ CE Mark Clinical Investigation Plan

Condition:   Advanced Refractory Left Ventricular Heart Failure
Intervention:   Device: Left Ventricular Assist System (LVAS)
Sponsors:   Thoratec Corporation;   Center for Life Sciences (C3TK);   Emergo Group;   Krakow Cardiovascular Research Institute
Active, not recruiting - verified February 2015

Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease

Condition:   Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention:   Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
Sponsor:   Raptor Pharmaceuticals Inc.
Recruiting - verified February 2015

Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers

Conditions:   Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP);   Transthyretin Cardiomyopathy (TTR-CM);   Familial Amyloid Cardiomyopathy;   Senile Systemic Amyloidosis (SSA)
Interventions:   Other: No drug;   Other: No drug
Sponsor:   Pfizer
Active, not recruiting - verified February 2015

Spironolactone in Adult Congenital Heart Disease

Conditions:   Congenital Heart Disease;   Heart Failure;   Endomyocardial Fibrosis
Interventions:   Drug: Spironolactone;   Other: Placebo
Sponsors:   Oregon Health and Science University;   National Heart, Lung, and Blood Institute (NHLBI);   Oregon Clinical and Translational Research Institute
Active, not recruiting - verified February 2015

Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

Condition:   TTR-CM
Intervention:   Drug: tafamidis
Sponsor:   Pfizer
Active, not recruiting - verified February 2015

Treating Clozapine-induced Sinustachycardia With Bisoprolol

Condition:   Clozapine-induced Sinustachycardia
Interventions:   Drug: Bisoprolol;   Drug: Placebo
Sponsors:   University of Aarhus;   Aalborg Universitetshospital  ;   Aalborg University
Recruiting - verified September 2013

Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)

Condition:   Anemia
Interventions:   Drug: Erythropoietin alpha;   Drug: Placebo
Sponsors:   Mathew S. Maurer;   National Institute on Aging (NIA)
Completed - verified February 2015

Get CardioSmart

You're Invited